IL-17B program to be presented at AACR 2017
OREGA will present latest in vivo data of its IL-17B program at the upcoming AACR annual conference to be held in Washington DC.
SESSION PO.IM02.06 - Cytokines: The First Modern Immunotherapies
April 3, 2017, 8:00 AM - 12:00 PM
1602 / 10 - Generation of anti-IL-17B antibodies neutralizing IL-17B-mediated alterations of the immune microenvironment, promotion of tumor cell initiating capacity and chemoresistance